HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kazumoto Shibuya Selected Research
Kazumoto Shibuya Research Topics
Disease
11
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2022 - 03/2011
8
POEMS Syndrome (Syndrome, POEMS)
05/2020 - 08/2012
4
Polyneuropathies (Polyneuropathy)
01/2019 - 06/2010
3
Disease Progression
03/2022 - 02/2011
3
Pain (Aches)
10/2018 - 12/2009
3
Neuralgia (Stump Neuralgia)
10/2018 - 12/2009
3
Paraproteinemias (Monoclonal Gammopathy)
04/2016 - 08/2012
3
Fasciculation (Fasciculations)
02/2012 - 11/2011
2
Myositis (Idiopathic Inflammatory Myopathies)
08/2021 - 01/2020
2
Ascites
04/2016 - 01/2013
2
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
10/2015 - 02/2011
2
Edema (Dropsy)
10/2015 - 01/2013
2
Demyelinating Diseases (Demyelinating Disease)
10/2015 - 08/2012
2
Guillain-Barre Syndrome
07/2014 - 01/2012
2
Lymphoma (Lymphomas)
01/2008 - 03/2003
2
Epilepsia Partialis Continua
07/2005 - 10/2004
2
Seizures (Absence Seizure)
07/2005 - 10/2004
1
Respiratory Insufficiency (Respiratory Failure)
08/2021
1
Rhabdomyolysis
08/2021
1
Myasthenia Gravis
08/2021
1
Muscular Diseases (Myopathy)
08/2021
1
Motor Neuron Disease (Primary Lateral Sclerosis)
01/2021
1
Pleuropneumonia
07/2020
1
Exanthema (Rash)
01/2020
1
Dermatitis
01/2020
1
Dermatomyositis (Dermatopolymyositis)
01/2020
1
Melanoma (Melanoma, Malignant)
01/2020
1
Andersen Syndrome
01/2019
1
Calciphylaxis
04/2016
1
Macular Degeneration (Age-Related Maculopathy)
10/2015
1
Atrophy
10/2015
1
Retinal Degeneration
10/2015
1
Neurilemmoma (Schwannoma)
07/2014
1
Infections
07/2014
1
Multiple Myeloma
02/2014
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2014
1
Peripheral Nerve Injuries
01/2014
1
Ataxia (Dyssynergia)
07/2013
1
Pleural Effusion (Pleural Effusions)
01/2013
1
Alexander Disease (Alexander's Disease)
09/2012
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
05/2020 - 03/2003
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2019 - 08/2012
5
Antibodies
IBA
08/2021 - 01/2012
4
Cytokines
IBA
04/2016 - 08/2012
4
Sodium
IBA
10/2015 - 05/2010
3
Autoantibodies
IBA
01/2020 - 07/2014
3
Potassium Channels (Potassium Channel)
IBA
01/2019 - 01/2011
3
Potassium
IBA
10/2015 - 11/2011
2
mecobalamin (methylcobalamin)
IBA
01/2022 - 01/2014
2
Interleukin-6 (Interleukin 6)
IBA
04/2016 - 08/2012
2
Mexiletine (Mexitil)
FDA Link
Generic
01/2015 - 05/2010
2
DNA-Binding Proteins (DNA Binding Protein)
IBA
09/2014 - 03/2011
2
salicylhydroxamic acid (SHAM)
IBA
10/2011 - 01/2008
2
erucylphosphocholine
IBA
07/2005 - 10/2004
1
Edaravone
IBA
03/2022
1
Free Radicals
IBA
03/2022
1
Riluzole
FDA Link
Generic
03/2022
1
anti-titin autoantibody
IBA
08/2021
1
Superoxide Dismutase-1
IBA
01/2021
1
Agar
IBA
07/2020
1
Thalidomide (Thalomid)
FDA Link
05/2020
1
Lenalidomide (CC 5013)
FDA Link
05/2020
1
Dexamethasone (Maxidex)
FDA Link
Generic
05/2020
1
nuclear matrix protein 2
IBA
01/2020
1
Janus Kinase Inhibitors
IBA
01/2020
1
Enzymes
IBA
01/2020
1
Staphylococcal Protein A (Protein A)
IBA
01/2020
1
Ubiquitin
IBA
01/2020
1
Inosine Monophosphate (IMP)
IBA
10/2018
1
Duloxetine Hydrochloride (Cymbalta)
FDA Link
10/2018
1
1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimide
IBA
01/2017
1
Phosphates (Orthophosphate)
IBA
04/2016
1
Calcium
IBA
04/2016
1
Creatinine
IBA
04/2016
1
Serum Albumin
IBA
04/2016
1
Vinculin
IBA
10/2015
1
Retinaldehyde (Retinal)
IBA
10/2015
1
Melanins (Melanin)
IBA
10/2015
1
Pharmaceutical Preparations
IBA
10/2015
1
Sodium Channel Blockers
IBA
01/2015
1
moesin
IBA
07/2014
1
Complement System Proteins (Complement)
IBA
07/2014
1
Epitopes
IBA
07/2014
1
Immunoglobulin G (IgG)
IBA
07/2014
1
Bortezomib (Velcade)
FDA Link
02/2014
1
Proteasome Inhibitors
IBA
02/2014
1
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
01/2014
1
Prions
IBA
01/2014
1
Monoclonal Antibodies
IBA
12/2013
1
Bevacizumab (Avastin)
FDA Link
12/2013
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2013
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
01/2013
1
Glial Fibrillary Acidic Protein
IBA
09/2012
1
Interleukin-12 (IL 12)
IBA
08/2012
1
Suspensions
IBA
08/2012
Therapy/Procedure
6
Therapeutics
01/2020 - 02/2011
2
Tracheostomy
01/2022 - 01/2020
2
Transcranial Magnetic Stimulation
01/2021 - 07/2005
1
Aftercare (After-Treatment)
10/2018
1
Transjugular Intrahepatic Portasystemic Shunt
07/2014